Parks L. Diane's most recent trade in Soligenix Inc was a trade of 17,647 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Soligenix Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 17,647 | 17,647 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 28,500 | 28,500 | - | - | Option to purchase common stock | |
| Celularity Inc Ordinary | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 84,746 | 362,524 | - | - | Stock Option (Right to Buy) | |
| Celularity Inc Ordinary | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 67,416 | 303,482 | - | 0 | Class A Common Stock | |
| Soligenix Inc | Diane Parks L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 8,646 | 8,646 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Soligenix Inc | Parks L. Diane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 38,136 | 38,136 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Soligenix Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 46,154 | 112,504 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Soligenix Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2021 | 29,126 | 29,126 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Soligenix Inc | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 15,228 | 15,228 | - | - | Stock Option (Right to Buy) |